UTAH MEDICAL PRODUCTS INC
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
UTMD$72.86-0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
INDEX TO FORM 10-Q
| PAGE | ||
|---|---|---|
| PART I - FINANCIAL INFORMATION | ||
| Item 1. · Financial Statements | ||
| Consolidated Condensed Balance Sheets as of June 30, 2024 and December 31, 2023 | 1 | |
| Consolidated Condensed Statements of Income for the three and six months ended June 30, 2024 and June 30, 2023 | 2 | |
| Consolidated Condensed Statements of Cash Flows for the six months ended June 30, 2024 and June 30, 2023 | 3 | |
| Consolidated Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2024 and June 30, 2023 | 4 | |
| Notes to Consolidated Condensed Financial Statements | 5 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 7 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 15 |
| Item 4. | Controls and Procedures | 15 |
| PART II – OTHER INFORMATION | ||
| Item 1. | Legal Proceedings | 16 |
| Item 1A. | Risk Factors | 16 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 17 |
| Item 6. | Exhibits | 18 |
| SIGNATURES | 18 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.